tetano
Editor, Senior Moderator
Heart Views
. Jul-Sep 2020;21(3):215-219.
doi: 10.4103/HEARTVIEWS.HEARTVIEWS_151_20. Epub 2020 Oct 13.
Non-ST Segment Elevation Myocardial Infarction in a Patient with COVID-19
Fahmi Othman[SUP] 1 [/SUP], Abdul Rehman Abid[SUP] 1 [/SUP], Mohammad Alibrahim[SUP] 1 [/SUP], Sabir Abdulkarim[SUP] 1 [/SUP], Mohammed A Abdelaty[SUP] 2 [/SUP], Mohamed Aboukamar[SUP] 3 [/SUP], Salah Arafah[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is associated with a wide spectrum of cardiovascular (CV) manifestations. Primary cardiac manifestations of COVID-19 disease include acute coronary syndrome (ACS), myocarditis, and arrhythmias. Secondary cardiac involvement is usually due to a systemic inflammatory syndrome and can manifest as acute myocardial injury/biomarker elevation and/or heart failure (congestive heart failure). Elevated cardiac biomarkers indicate an unfavorable prognosis. Health-care systems of the world are rapidly learning more about the manifestations of COVID-19 on the CV system, as well as the strategies for the management of infected patients with CV disease. There is still a paucity of literature on the management of non-ST-segment elevation ACSs in the current literature. Herein, we report the case of a 53-year-old male patient, who presented with severe COVID-19 pneumonia deteriorating into adult respiratory distress syndrome requiring mechanical ventilation. The patient had a history of coronary artery disease. During the course of treatment, he developed sudden cardiac arrest with diffuse ST-segment depression, which was treated by percutaneous coronary intervention to the left anterior descending artery. The patient had a favorable outcome with excellent recovery from the disease.
Keywords: Adult respiratory distress syndrome; COVID-19; non-ST segment elevation myocardial infarction; percutaneous coronary intervention; sudden cardiac arrest.
. Jul-Sep 2020;21(3):215-219.
doi: 10.4103/HEARTVIEWS.HEARTVIEWS_151_20. Epub 2020 Oct 13.
Non-ST Segment Elevation Myocardial Infarction in a Patient with COVID-19
Fahmi Othman[SUP] 1 [/SUP], Abdul Rehman Abid[SUP] 1 [/SUP], Mohammad Alibrahim[SUP] 1 [/SUP], Sabir Abdulkarim[SUP] 1 [/SUP], Mohammed A Abdelaty[SUP] 2 [/SUP], Mohamed Aboukamar[SUP] 3 [/SUP], Salah Arafah[SUP] 1 [/SUP]
Affiliations
- PMID: 33688414
- PMCID: PMC7898994
- DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_151_20
Abstract
Coronavirus disease 2019 (COVID-19) is associated with a wide spectrum of cardiovascular (CV) manifestations. Primary cardiac manifestations of COVID-19 disease include acute coronary syndrome (ACS), myocarditis, and arrhythmias. Secondary cardiac involvement is usually due to a systemic inflammatory syndrome and can manifest as acute myocardial injury/biomarker elevation and/or heart failure (congestive heart failure). Elevated cardiac biomarkers indicate an unfavorable prognosis. Health-care systems of the world are rapidly learning more about the manifestations of COVID-19 on the CV system, as well as the strategies for the management of infected patients with CV disease. There is still a paucity of literature on the management of non-ST-segment elevation ACSs in the current literature. Herein, we report the case of a 53-year-old male patient, who presented with severe COVID-19 pneumonia deteriorating into adult respiratory distress syndrome requiring mechanical ventilation. The patient had a history of coronary artery disease. During the course of treatment, he developed sudden cardiac arrest with diffuse ST-segment depression, which was treated by percutaneous coronary intervention to the left anterior descending artery. The patient had a favorable outcome with excellent recovery from the disease.
Keywords: Adult respiratory distress syndrome; COVID-19; non-ST segment elevation myocardial infarction; percutaneous coronary intervention; sudden cardiac arrest.